Acellbia 10 mg/ml 30 ml

The active component of Acellbia® is rituximab, a chimeric mouse/human monoclonal antibody that binds specifically to the CD20 transmembrane antigen.

Indications

Non-Hodgkin’s Lymphoma

– Recurrent or chemoresistant B-cell, C020-positive non-Hodgkin’s lymphoma of low-grade malignancy or follicular.

– Follicular lymphoma stage III-IV in combination with chemotherapy in previously untreated patients.

– Follicular lymphoma as maintenance therapy after response to induction therapy.

– C020-positive diffuse B-cell non-Hodgkin’s lymphoma in combination with CHOP chemotherapy.

Cronic lympholeukemia

Cronic lympholeukemia in combination with chemotherapy in patients who have not previously received standard therapy.

Recurrent or chemoresistant chronic lympholeukemia in combination with chemotherapy.

Active ingredient

Composition

How to take, the dosage

Interaction

Special Instructions

Contraindications

Side effects

Overdose

Pregnancy use